Anxiety Disorders in the Middle East and North Africa region: A Comprehensive Analysis from 1990 to 2021.

IF 2.6 4区医学 Q3 NEUROSCIENCES

Acta Neuropsychiatrica Pub Date : 2025-06-30 DOI:10.1017/neu.2025.10023

Reza Aletaha, Ali-Asghar Kolahi, Zahra Mousavi, Mark J M Sullman, Saeid Safiri

{"title":"Anxiety Disorders in the Middle East and North Africa region: A Comprehensive Analysis from 1990 to 2021.","authors":"Reza Aletaha, Ali-Asghar Kolahi, Zahra Mousavi, Mark J M Sullman, Saeid Safiri","doi":"10.1017/neu.2025.10023","DOIUrl":null,"url":null,"abstract":"Objective: This study presents the most recent data on the incidence, prevalence, and years lived with disability (YLDs) due to anxiety disorders across the Middle East and North Africa (MENA) region from 1990-2021, analysed by sex, age, and sociodemographic index (SDI).Methods: We assessed the burden of anxiety disorders using data sourced from the Global Burden of Disease 2021 study. The estimates of prevalence, DALYs, and YLDs are provided as numbers and age-standardised rates, accompanied by their 95% uncertainty intervals (UIs).Results: In 2021, the age-standardised point prevalence of anxiety disorders in the region was 5.95 thousand, with an incidence rate of 883.4 per 100,000. The number of YLDs in 2021 reached 4.5 million. From 1990 to 2021, the burden of anxiety disorders increased significantly. Lebanon had the highest burden in 2021. Among both sexes, the 10-14 age group had the highest incidence rate, while the 15-19 age group had the highest prevalence and YLD rates. In 2021, most age groups in the MENA region had YLD rates that were higher than the global average.Conclusion: This study highlights the urgent need for a multidisciplinary approach to prevent and manage anxiety disorders. Ensuring accessible and affordable treatment options for all affected individuals is crucial. Governments should prioritise supporting programmes to effectively address mental health issues, given the unique socioeconomic and geopolitical challenges in the MENA region. By including effective preventive methods alongside treatment in healthcare strategies, the burden of anxiety disorders can be significantly reduced.","PeriodicalId":48964,"journal":{"name":"Acta Neuropsychiatrica","volume":" ","pages":"1-46"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neuropsychiatrica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/neu.2025.10023","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: This study presents the most recent data on the incidence, prevalence, and years lived with disability (YLDs) due to anxiety disorders across the Middle East and North Africa (MENA) region from 1990-2021, analysed by sex, age, and sociodemographic index (SDI).

Methods: We assessed the burden of anxiety disorders using data sourced from the Global Burden of Disease 2021 study. The estimates of prevalence, DALYs, and YLDs are provided as numbers and age-standardised rates, accompanied by their 95% uncertainty intervals (UIs).

Results: In 2021, the age-standardised point prevalence of anxiety disorders in the region was 5.95 thousand, with an incidence rate of 883.4 per 100,000. The number of YLDs in 2021 reached 4.5 million. From 1990 to 2021, the burden of anxiety disorders increased significantly. Lebanon had the highest burden in 2021. Among both sexes, the 10-14 age group had the highest incidence rate, while the 15-19 age group had the highest prevalence and YLD rates. In 2021, most age groups in the MENA region had YLD rates that were higher than the global average.

Conclusion: This study highlights the urgent need for a multidisciplinary approach to prevent and manage anxiety disorders. Ensuring accessible and affordable treatment options for all affected individuals is crucial. Governments should prioritise supporting programmes to effectively address mental health issues, given the unique socioeconomic and geopolitical challenges in the MENA region. By including effective preventive methods alongside treatment in healthcare strategies, the burden of anxiety disorders can be significantly reduced.

查看原文本刊更多论文

中东和北非地区焦虑症：1990年至2021年的综合分析。

目的：本研究介绍了1990-2021年中东和北非（MENA）地区因焦虑症导致的发病率、患病率和残疾生活年数（YLDs）的最新数据，并按性别、年龄和社会人口指数（SDI）进行了分析。方法：我们使用来自2021年全球疾病负担研究的数据评估焦虑症的负担。患病率、DALYs和YLDs的估计值以数字和年龄标准化率的形式提供，并附有95%的不确定区间（UIs）。结果：2021年，该地区焦虑障碍年龄标准化点患病率为595万，发病率为883.4 / 10万。到2021年，yld的数量达到450万。从1990年到2021年，焦虑症的负担显著增加。黎巴嫩在2021年的负担最高。在两性中，10-14岁年龄组发病率最高，而15-19岁年龄组患病率和YLD率最高。2021年，中东和北非地区大多数年龄组的青少年死亡率高于全球平均水平。结论：本研究强调了迫切需要多学科方法来预防和管理焦虑症。确保为所有受影响的个人提供可获得和负担得起的治疗选择至关重要。鉴于中东和北非地区独特的社会经济和地缘政治挑战，各国政府应优先支持有效解决心理健康问题的方案。通过在保健战略中包括有效的预防方法和治疗，可以显著减少焦虑症的负担。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Neuropsychiatrica NEUROSCIENCES-PSYCHIATRY

自引率

5.30%

发文量

期刊介绍： Acta Neuropsychiatrica is an international journal focussing on translational neuropsychiatry. It publishes high-quality original research papers and reviews. The Journal''s scope specifically highlights the pathway from discovery to clinical applications, healthcare and global health that can be viewed broadly as the spectrum of work that marks the pathway from discovery to global health.